Literature DB >> 280729

[Effector function of acute leukemias in "spontaneous" (SCMC) and antibody dependent cellular cytotoxicity-tests (ADCC) (author's transl)].

P Schmidt, H H Peter, J R Kalden, H J Avenarius, H Bodenstein.   

Abstract

Blood lymphocytes from 13 untreated acute leukemia patients, 3 pre-leukemias 3 immunoblastic lymphadenopathias and one infectious mononucleosis showed significantly lower spontaneous (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) against 51Cr-labeled allogeneic melanoma cells of the IGR3 cell line than effector lymphocytes from 20 age- and sex matched control persons. While control lymphocytes exhibited the highest cytotoxic activity after depletion of mononuclear phagocytes (Fraction FFF), followed by the "Ficoll" purified Fraction F and defibrinated whole blood, the reverse was true for acute leukemias: here, the highest cytotoxicity was found in whole blood followed by the lymphocyte fractions F and FFF. Comparatively high cytotoxicity was found with two leukemia patients who had received blood transfusions the day before testing. During the course of an acute erythroleukemia chemotherapy drastically reduced SCMC and ADCC activities. A therapeutical splenectomy, on the other hand, did not affect cellular cytotoxicity in the case of a hairy cell leukemia. The angioimmunoblastic lymphadenopathies showed strikingly high percentages of EA- and EAC-rosettes forming cells and showed a marked increase of SCMC and ADCC activities after elimination of mononuclear phagocytes from the effector cell population.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 280729     DOI: 10.1007/bf01480149

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  34 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

Authors:  E Svedmyr; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Selective cellular natural killing against human leukaemic T cells and thymus.

Authors:  A Ono; D B Amos; H S Koren
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

4.  Antibody in the induction and inhibition of lymphocyte cytotoxicity.

Authors:  I C MacLennan
Journal:  Transplant Rev       Date:  1972

5.  Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells.

Authors:  P Perlmann; H Perlmann; H Wigzell
Journal:  Transplant Rev       Date:  1972

6.  Reactivity of lymphocytes from normal persons on cultured tumor cells.

Authors:  M Takasugi; M R Mickey; P I Terasaki
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

7.  Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas.

Authors:  R S Kerbel; H F Pross; E V Elliott
Journal:  Int J Cancer       Date:  1975-06-15       Impact factor: 7.396

8.  Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).

Authors:  H H Peter; J Pavie-Fischer; W H Fridman; C Aubert; J P Cesarini; R Roubin; F M Kourilsky
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

9.  Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease.

Authors:  H F Pross; M G Baines
Journal:  Int J Cancer       Date:  1976-11-15       Impact factor: 7.396

10.  In vitro "education" on autologous human sarcoma generates non-specific killer cells.

Authors:  M R Martin-Chandon; F Vanky; C Carnaud; E Klein
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

View more
  2 in total

1.  Impaired T-cell and NK-cell function in patients with preleukemia.

Authors:  F Porzsolt; H Heimpel
Journal:  Blut       Date:  1982-10

2.  The origin of human NK cells. An ontogenic model derived from studies in patients with immunodeficiencies.

Authors:  H H Peter
Journal:  Blut       Date:  1983-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.